Citigroup’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-100,000
| Closed | -$34.6M | – | 5755 |
|
|
2025
Q1 | $34.6M | Buy |
100,000
+88,000
| +733% | +$28.3M | 0.02% | 715 |
|
|
2024
Q4 | $3.6M | Hold |
12,000
| – | – | ﹤0.01% | 2287 |
|
|
2024
Q3 | $4.88M | Sell |
12,000
-16,300
| -58% | -$5.97M | ﹤0.01% | 1867 |
|
|
2024
Q2 | $9.09M | Buy |
28,300
+9,300
| +49% | +$3.02M | 0.01% | 1302 |
|
|
2024
Q1 | $6.34M | Sell |
19,000
-16,000
| -46% | -$4.89M | ﹤0.01% | 1550 |
|
|
2023
Q4 | $9.47M | Sell |
35,000
-6,500
| -16% | -$1.61M | 0.01% | 1249 |
|
|
2023
Q3 | $10.2M | Buy |
41,500
+19,500
| +89% | +$5.34M | 0.01% | 1092 |
|
|
2023
Q2 | $6.68M | Buy |
22,000
+6,000
| +38% | +$1.67M | ﹤0.01% | 1329 |
|
|
2023
Q1 | $4.22M | Sell |
16,000
-9,500
| -37% | -$2.41M | ﹤0.01% | 1588 |
|
|
2022
Q4 | $6.12M | Sell |
25,500
-227,500
| -90% | -$51M | ﹤0.01% | 1370 |
|
|
2022
Q3 | $46.5M | Buy |
+253,000
| New | +$50.4M | 0.03% | 399 |
|
|
2021
Q2 | – | Sell |
-25,000
| Closed | -$4.71M | – | 6240 |
|
|
2021
Q1 | $4.71M | Buy |
25,000
+8,600
| +52% | +$1.52M | ﹤0.01% | 1819 |
|
|
2020
Q4 | $2.7M | Sell |
16,400
-8,900
| -35% | -$1.3M | ﹤0.01% | 2576 |
|
|
2020
Q3 | $3.15M | Buy |
25,300
+4,100
| +19% | +$507K | ﹤0.01% | 2260 |
|
|
2020
Q2 | $2.06M | Sell |
21,200
-13,200
| -38% | -$1.37M | ﹤0.01% | 2783 |
|
|
2020
Q1 | $3.09M | Buy |
34,400
+15,600
| +83% | +$2.02M | ﹤0.01% | 2076 |
|
|
2019
Q4 | $2.78M | Sell |
18,800
-2,900
| -13% | -$389K | ﹤0.01% | 2634 |
|
|
2019
Q3 | $2.61M | Sell |
21,700
-53,100
| -71% | -$6.86M | ﹤0.01% | 2571 |
|
|
2019
Q2 | $10.1M | Buy |
74,800
+68,800
| +1,147% | +$8.7M | 0.01% | 1384 |
|
|
2019
Q1 | $782K | Sell |
6,000
-105,100
| -95% | -$14.1M | ﹤0.01% | 3679 |
|
|
2018
Q4 | $13.8M | Buy |
111,100
+48,800
| +78% | +$6.55M | 0.01% | 1041 |
|
|
2018
Q3 | $8.67M | Sell |
62,300
-1,000
| -2% | -$124K | 0.01% | 1387 |
|
|
2018
Q2 | $6.5M | Sell |
63,300
-30,200
| -32% | -$3.06M | 0.01% | 1609 |
|
|
2018
Q1 | $9.07M | Buy |
93,500
+24,400
| +35% | +$2.37M | 0.01% | 1309 |
|
|
2017
Q4 | $6.07M | Buy |
69,100
+16,400
| +31% | +$1.32M | ﹤0.01% | 1656 |
|
|
2017
Q3 | $4.19M | Buy |
52,700
+28,200
| +115% | +$2.27M | ﹤0.01% | 1929 |
|
|
2017
Q2 | $2.14M | Sell |
24,500
-278,200
| -92% | -$23.5M | ﹤0.01% | 2521 |
|
|
2017
Q1 | $26.9M | Buy |
302,700
+197,100
| +187% | +$16.4M | 0.02% | 621 |
|
|
2016
Q4 | $7.82M | Sell |
105,600
-59,800
| -36% | -$4.48M | 0.01% | 1389 |
|
|
2016
Q3 | $12.5M | Buy |
165,400
+82,100
| +99% | +$6.29M | 0.01% | 934 |
|
|
2016
Q2 | $6.42M | Sell |
83,300
-5,700
| -6% | -$450K | 0.01% | 1353 |
|
|
2016
Q1 | $6.95M | Sell |
89,000
-429,300
| -83% | -$30M | 0.01% | 1277 |
|
|
2015
Q4 | $35.1M | Buy |
518,300
+56,000
| +12% | +$3.91M | 0.03% | 487 |
|
|
2015
Q3 | $35.8M | Sell |
462,300
-59,700
| -11% | -$5.29M | 0.03% | 453 |
|
|
2015
Q2 | $47.4M | Buy |
522,000
+30,600
| +6% | +$2.45M | 0.04% | 413 |
|
|
2015
Q1 | $37M | Sell |
491,400
-153,600
| -24% | -$11M | 0.04% | 466 |
|
|
2014
Q4 | $47.3M | Buy |
645,000
+55,500
| +9% | +$3.9M | 0.04% | 424 |
|
|
2014
Q3 | $41.6M | Buy |
589,500
+24,600
| +4% | +$1.63M | 0.04% | 460 |
|
|
2014
Q2 | $31.8M | Buy |
564,900
+60,500
| +12% | +$3.19M | 0.03% | 534 |
|
|
2014
Q1 | $26.5M | Sell |
504,400
-120,500
| -19% | -$6M | 0.03% | 580 |
|
|
2013
Q4 | $29.8M | Buy |
624,900
+486,100
| +350% | +$22.5M | 0.03% | 576 |
|
|
2013
Q3 | $5.93M | Buy |
138,800
+91,400
| +193% | +$3.57M | 0.01% | 1607 |
|
|
2013
Q2 | $1.71M | Buy |
+47,400
| New | +$1.83M | ﹤0.01% | 2483 |
|
Other funds holding HCA
VCM
VPM
Citigroup's HCA Position: Q1 2026 in Review
Citigroup reduced its HCA Healthcare (HCA) stake by 0.99% in Q1 2026, selling an estimated $1.18M and leaving 233,479 shares worth $110M. The position accounts for 0.05% of the portfolio, ranked #375.
Citigroup first reported a position in HCA in Q2 2013 and has held it in 52 quarters since. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- Citigroup held 233,479 shares of HCA Healthcare worth $110M as of Q1 2026.
- Citigroup sold 2,343 HCA Healthcare shares in Q1 2026, an estimated $1.18M.
- HCA Healthcare made up 0.05% of Citigroup's portfolio in Q1 2026, its #375 holding.
- Citigroup first reported a position in HCA Healthcare in Q2 2013 and has held it in 52 quarters since.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.